Hearing loss results from damage to the inner ear, and can lead to degeneration of auditory nerve fibers and anatomic structures central to the peripheral sites of lesion. Importantly, there is growing effort to cure hearing loss using stem cells and other genetic treatments. Unfortunately, clinical diagnostic tests do not specifically identify the location of the insult that creates hearing loss, or describes the physiology of the remaining structures. Thus new diagnostic tests are needed that identify the site(s) of damage so that biologic treatments can be targeted to the specific location. The long term goal of this research is to develop these clinical tests. Patients with hearing loss vary considerably in their perceptual performance as well as their satisfaction with hearing aids and cochlear implants. An important variable in the heterogeneity is illustrated from animal studies and cadaver studies where subjects with similar hearing loss show a variety of anatomic damage. One source of variability is in the population of auditory nerve fibers. Auditory nerve fibers may degenerate in some patients whereas in others a full complement remains. Moreover, a recent finding in an animal model is that even temporary hearing loss, due to loud sound exposure, can cause auditory nerve degeneration without permanent changes in the clinical measures of hearing. This ?hidden hearing loss? along with the degeneration of auditory nerve fibers in patients with hearing loss motivates the research in this proposal to develop a biomarker for auditory nerve survival. The acoustic middle ear muscle (MEM) reflex may serve as an index of auditory nerve survival. The anatomic circuit includes the auditory nerve, and the reflex is sensitive to stretching or compressing the auditory nerve. Measuring the MEM reflex is a standard procedure in Audiology clinics and is used to identify auditory nerve tumors or space-occupying tumors compressing the auditory nerve.
The specific aim of this proposal is to determine if the MEM reflex can be used as a biomarker for auditory nerve degeneration. This is accomplished by recording the MEM reflex in an animal model before and after the application of a drug to create neural degeneration. If successful, this biomarker could be used to identify patients with neural degeneration in order to target this site for tissue transplantation. Moreover, determining the extent of neural survival will be useful for predicting successful candidates for cochlear implants and hearing aids, as well as counselling those patients with ?hidden hearing loss?.

Public Health Relevance

Aging, noise, and drugs can lead to a loss of auditory nerve fibers, and ultimately cause hearing impairment. The goal of this research is to develop a diagnostic test to identify the number of functioning auditory nerve fibers in individuals with hearing loss. A new diagnostic test will identify the locus of damage for future stem cell and other genetic treatments to cure hearing loss.

Agency
National Institute of Health (NIH)
Institute
National Institute on Deafness and Other Communication Disorders (NIDCD)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21DC015038-02
Application #
9283551
Study Section
Auditory System Study Section (AUD)
Program Officer
Cyr, Janet
Project Start
2016-08-01
Project End
2019-07-31
Budget Start
2017-08-01
Budget End
2019-07-31
Support Year
2
Fiscal Year
2017
Total Cost
Indirect Cost
Name
University of Kansas
Department
Other Health Professions
Type
Sch Allied Health Professions
DUNS #
016060860
City
Kansas City
State
KS
Country
United States
Zip Code
66160
Chertoff, Mark E; Martz, Ashley; Sakumura, Joey T et al. (2018) The Middle Ear Muscle Reflex in Rat: Developing a Biomarker of Auditory Nerve Degeneration. Ear Hear 39:605-614